Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

XTLB

XTL Biopharmaceuticals Ltd.

Healthcare · USD

Set alert

Price alert · XTLB

All alert types
1.61 USD -0.15 -8.52%
As of Oct 30, 2026 Extended hours 1.79 +11.02%
Bid
1.60 × 2
Ask
1.75 × 10
1.61 Day range 1.69
1.61 52-week range 4.32
YTD
-30.60%
1 year
-62.73%
Open
1.65
Prev close
1.76
Mkt cap
3.96M
Vol
8.60K
Avg vol
7.97K
EPS
-0.36
P/E
0.00
Div yield
0.00%
More statistics
Low
1.61
High
1.69
Forward P/E
0.00
Beta
1.00
Short ratio
3.35
Inst. own
1.92%
Dividend
0.00
Ex-div date
Earnings
Dec 25, 2024
50-d avg
1.84
200-d avg
2.32
1y target
0.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for XTLB has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-1416.06 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

D+1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -0.1×
FY 2016: -0.8×FY 2017: -3.6×FY 2018: 0.7×FY 2019: -1.3×FY 2020: -1.3×FY 2021: 8.7×FY 2022: -1.2×FY 2023: -0.1×FY 2024: -3.4×FY 2025: -0.1×
FY 2016 5y median -0.1× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 7.6×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B -3.8×
FY 2016: 0.8×FY 2017: 0.8×FY 2018: 0.3×FY 2019: 0.3×FY 2020: 1.1×FY 2021: 0.7×FY 2022: 0.4×FY 2023: 0.6×FY 2024: 0.6×FY 2025: -3.8×
FY 2016 5y median 0.6× FY 2025
P/FCF -1.0×
FY 2016: -1.2×FY 2017: -2.5×FY 2018: -2.7×FY 2019: -1.9×FY 2020: -4.6×FY 2021: -3.5×FY 2022: -1.8×FY 2023: -1.9×FY 2024: -2.0×FY 2025: -1.0×
FY 2016 5y median -1.9× FY 2025
EV/EBITDA -1.6×
FY 2016: -0.1×FY 2017: 0.3×FY 2018: 1.3×FY 2019: 0.0×FY 2020: -0.3×FY 2021: -0.7×FY 2022: 0.5×FY 2023: 0.0×FY 2024: -3.4×FY 2025: -1.6×
FY 2016 5y median -0.7× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 7.1×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -105.0%
FY 2016: -83.3%FY 2017: -39.2%FY 2018: -36.7%FY 2019: -51.7%FY 2020: -21.8%FY 2021: -28.5%FY 2022: -54.7%FY 2023: -51.4%FY 2024: -49.0%FY 2025: -105.0%
FY 2016 5y median -51.4% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.7%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -481.6%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -227.7%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE 2743.7%
FY 2016: -94.7%FY 2017: -21.6%FY 2018: 35.9%FY 2019: -19.3%FY 2020: -21.7%FY 2021: 8.2%FY 2022: -33.7%FY 2023: -0.1%FY 2024: -18.9%FY 2025: 2743.7%
FY 2016 5y median -0.1% FY 2025
ROIC -11253.3%
FY 2016: -95.3%FY 2017: -19.8%FY 2018: -9.5%FY 2019: -11.4%FY 2020: -15.2%FY 2021: -16.1%FY 2022: -22.0%FY 2023: -34.5%FY 2024: -29.7%FY 2025: -11253.3%
FY 2016 5y median -29.7% FY 2025
ROA -4198.2%
FY 2016: -84.4%FY 2017: -11.9%FY 2018: 34.8%FY 2019: -18.7%FY 2020: -12.0%FY 2021: 6.6%FY 2022: -32.2%FY 2023: -0.1%FY 2024: -12.0%FY 2025: -4198.2%
FY 2016 5y median -12.0% FY 2025

Growth (YoY)

Revenue -100.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -100.0%
FY 2016 FY 2025
Operating Income 22.3%
FY 2016: 29.1%FY 2017: 51.3%FY 2018: 36.4%FY 2019: -6.2%FY 2020: -12.6%FY 2021: -8.8%FY 2022: 14.6%FY 2023: 13.1%FY 2024: -183.9%FY 2025: 22.3%
FY 2016 FY 2025
EPS (diluted) -566.7%
FY 2016: 42.9%FY 2017: 81.7%FY 2018: 441.2%FY 2019: -144.8%FY 2020: -119.2%FY 2021: 112.3%FY 2022: -457.1%FY 2023: -650.0%FY 2024: 92.0%FY 2025: -566.7%
FY 2016 FY 2025
Free Cash Flow 38.7%
FY 2016: 6.7%FY 2017: 37.4%FY 2018: 27.5%FY 2019: -11.5%FY 2020: 6.5%FY 2021: -23.3%FY 2022: 14.1%FY 2023: 21.5%FY 2024: -136.5%FY 2025: 38.7%
FY 2016 FY 2025

Financial Health

Current Ratio 0.4×
FY 2016: 8.3×FY 2017: 20.7×FY 2018: 32.4×FY 2019: 29.4×FY 2020: 24.1×FY 2021: 27.0×FY 2022: 20.4×FY 2023: 9.9×FY 2024: 0.6×FY 2025: 0.4×
FY 2016 5y median 9.9× FY 2025
Quick Ratio 0.4×
FY 2016: 8.0×FY 2017: 20.4×FY 2018: 32.4×FY 2019: 29.4×FY 2020: 24.1×FY 2021: 27.0×FY 2022: 20.4×FY 2023: 9.9×FY 2024: 0.6×FY 2025: 0.4×
FY 2016 5y median 9.9× FY 2025
Debt / Equity -1.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: -1.1×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -0.3×
FY 2016: 1.2×FY 2017: 2.6×FY 2018: 4.1×FY 2019: 0.0×FY 2020: 3.8×FY 2021: 2.9×FY 2022: 2.4×FY 2023: 1.8×FY 2024: 0.3×FY 2025: -0.3×
FY 2016 5y median 1.8× FY 2025
Interest Coverage -241×
FY 2016: 0.0×FY 2017: -156×FY 2018: -113×FY 2019: -29.0×FY 2020: -55.8×FY 2021: -49.1×FY 2022: -80.0×FY 2023: -191×FY 2024: -25.3×FY 2025: -241×
FY 2016 5y median -80.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31